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Iron induces insulin resistance in 
cardiomyocytes via regulation of 
oxidative stress
Hye Kyoung sung1, erfei song  1, James Won suk Jahng1, Kostas pantopoulos  2 & 
Gary sweeney1
Iron overload is associated with various pathological changes which contribute to heart failure. 
Here, we examined mechanisms via which iron alters cardiomyocyte insulin sensitivity. treatment of 
primary adult and neonatal cardiomyocytes as well as H9c2 cells with iron decreased insulin sensitivity 
determined via Western blotting or immunofluorescent detection of Akt and p70S6K phosphorylation 
and glucose uptake. Using CellROX deep red or DCF-DA probes we also observed that iron increased 
generation of reactive oxygen species (Ros), and that pretreatment with the superoxide dismutase 
mimetic MnTBAP reduced ROS production and attenuated iron-induced insulin resistance. SKQ1 and 
allopurinol but not apocynin reduced iron-induced Ros suggesting mitochondria and xanthine oxidase 
contribute to cellular ROS in response to iron. Western blotting for LC3-I, LC3-II and P62 levels as well 
as immunofluorescent co-detection of autophagosomes with Cyto-ID and lysosomal cathepsin activity 
indicated that iron attenuated autophagic flux without altering total expression of Atg7 or beclin-1 
and phosphorylation of mTORC1 and ULK1. This conclusion was reinforced via protein accumulation 
detected using Click-iT HPG labelling after iron treatment. The adiponectin receptor agonist AdipoRon 
increased autophagic flux and improved insulin sensitivity both alone and in the presence of iron. We 
created an autophagy-deficient cell model by overexpressing a dominant-negative Atg5 mutant in 
H9c2 cells and this confirmed that reduced autophagy flux correlated with less insulin sensitivity. In 
conclusion, our study showed that iron promoted a cascade of Ros production, reduced autophagy and 
insulin resistance in cardiomyocytes.
Iron is an essential micronutrient and its crucial role in many physiological functions is often underestimated1. 
Altered iron metabolism is implicated in a vast array of diseases, including type 2 diabetes1, neurodegenerative 
diseases2, cardiovascular diseases3, cancer4, osteoporosis5 and many more. In particular, both iron deficiency 
(ID) and iron overload (IO) have been associated with cardiomyopathy3. Recently, iron overload cardiomyopathy 
(IOC) has been described as a secondary form of cardiomyopathy resulting from the accumulation of iron in the 
myocardium mainly because of genetically determined disorders of iron metabolism or multiple transfusions6. 
Iron is a vital structural component of hemoglobin, myoglobin, oxidative enzymes and respiratory chain proteins 
that are collectively responsible for oxygen transport, storage, and energy metabolism7. Iron-overload cardiomy-
opathy is the most common reason for mortality in patients with secondary iron overload or patients with early 
onset forms of genetic hemochromatosis8.
In essence, altered iron homeostasis leads to uncontrolled iron deposition in different organs, including the 
heart, leading to progressive tissue damage8. Iron-induced oxidative stress plays an important role in the patho-
genesis of iron-overload mediated heart disease9,10. The formation of labile NTBI alters the pro-oxidant/antiox-
idant balance, leading to a pro-oxidant state with increased free radical production, oxidative stress and cellular 
damage11. Previous studies indicated that oxidative stress can lead to mitochondrial dysfunction and accumula-
tion of lipotoxic metabolites which have been shown to contribute to insulin resistance12,13.
Autophagy is a cellular degradation process capable of clearing damaged mitochondria and protein aggre-
gates14,15. Autophagy has been called a double-edged sword as it can have either beneficial or detrimental effects 
on the heart16. Recent evidence indicated that dysregulation of autophagy resulted in ER stress, insulin resistance 
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and glucose intolerance17. Our own research also has shown that induction of autophagy can be beneficial to 
the myocardium in terms of its insulin-sensitizing effect and reduce apoptosis18. In various tissue types, it has 
been found that ROS production results in increased autophagy19. In the heart, elevated autophagy is activated 
post-ischemia in association with ROS upregulation and this is thought to be an endogenous self-protective 
mechanism20. ROS also play an early role in the development of insulin resistance21. Evidence suggested that 
downstream of the PI3K/Akt insulin signaling pathway may be the target of exogenous inducers of autophagy22.
The precise molecular mechanisms of iron-overload cardiomyopathy have not been elucidated yet. In this 
study, we hypothesized that iron induces insulin resistance in cardiomyocytes and that this involves regulation 
of autophagy and/or oxidative stress and crosstalk between them. To do so, we used primary adult or neonatal 
cardiomyocytes and H9c2 cells as cellular models and treated with iron for up to 24 h and tested ROS production, 
autophagic flux, and insulin sensitivity.
Results
systemic administration of iron induced insulin resistance in mice. We first generated an ani-
mal model in which injection of iron caused a reduction in myocardial insulin sensitivity after 24 hr. Mice were 
injected with iron dextran at 15 mg per kg via tail vein three times, with two hours intervals, to induce iron over-
load. As expected, the ferritin content of plasma was significantly greater in the iron overload (IO) group, than 
wild type (wt) group (Fig. 1A). Using a ferrozine-based assay to detect intracellular iron in heart homogenates 
(Fig. 1B) and Perl’s Prussian blue staining of cardiac tissue sections (Fig. 1C), we found that there was a small but 
significant increase in iron accumulation in IO mice. We then injected insulin via tail vein to determine cardiac 
sensitivity to insulin. Our data indicated reduced insulin-stimulated phosphorylation of insulin receptor (Y972), 
insulin receptor substrate-1 (Y612) and Akt (T308) after iron overload (Fig. 1D–F).
Intracellular iron accumulation induced insulin resistance in H9c2 cells. We next used an in vitro 
model of iron overload in the H9c2 cardiomyoblast cell line derived from rat ventricle. After treatment with iron 
Figure 1. Iron overload significantly induced insulin resistance. Characterizing intracellular iron by serum 
ferritin (A), Colorimetric assay (B) and Perl’s Prussian blue staining (C) from wt and IO mice. Western blots 
showing phosphorylation of IR Tyr 972, (D) IRS-1 Tyr 612 (E) and AKT T308 (F) and the reference protein, 
GAPDH and total AKT, in heart tissue lysates from wt and IO mice. The images were collected from two gels 
with same loading amounts. The blot gels shown are representatives of three different experiments (n = 3). 
*Indicates significant difference from wt without insulin *p < 0.05, #indicates significant difference from wt 
with insulin #p < 0.05, Scale bar PB = 100 μm.
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for 1, 4 and 24 hr a colorimetric intracellular iron assay was conducted by adding ferrozine to H9c2 cell lysates 
(Fig. 2A). In addition, the fluorescent dye PGSK which is quenched by iron was preloaded into cells 30 minutes 
before iron treatment and compared to cells cultured for the same time period without iron treatment (Fig. 2B,C). 
Both assays showed a time-dependent increase in intracellular iron accumulation from 1 to 24 hr. We next exam-
ined the effects of iron on insulin sensitivity in these cells via Western blotting detection of Akt phosphorylation 
and the data indicated that the response to insulin was significantly attenuated after 4 or 24 hr iron overload 
(Fig. 2D,E). We further confirmed that iron blunted insulin signalling by detection of p70S6K phosphorylation 
(Fig. 2F,G).
Iron overload induced insulin resistance in primary adult and neonatal rat cardiomyocytes. 
After our initial observation that iron induced insulin resistance in H9c2 cells, we examined whether the same 
phenomenon was observed in primary cardiomyocytes. First, we isolated primary neonatal rat cardiomyocytes 
and observed that after 4 and 24 hr iron treatment there was a decrease in Akt phosphorylation detected by 
immunofluorescence (Fig. 3A,B) and Western blotting (Fig. 3C,D). In addition, the metabolic significance of 
these effects was examined by measuring glucose uptake in primary neonatal rat cardiomyocytes. We observed 
that iron significantly attenuated insulin-stimulated glucose uptake (Fig. 3E). Furthermore, we then isolated pri-
mary adult rat cardiomyocytes and used immunofluorescent detection of Akt phosphorylation to show that insu-
lin signaling was significantly attenuated by iron treatment in these cells (Fig. 3F,G).
Figure 2. Intracellular iron accumulation induced insulin resistance in cardiomyocyte. H9c2 cells were 
treated with FeSO4 (100 μM) or without (con) for 1, 4 and 24 hrs. Colorimetric assay (A) and PGSK assay (B) 
showing intracellular iron, followed by its quantification (C). H9c2 cells without (con) or with FeSO4 (100 μM) 
were treated with insulin (100 nM) for 10 minutes before experimental endpoint. Western blots showing 
phosphorylation of AKT T308 and the reference protein, total AKT (D), phosphorylation of p70S6K T389 and 
the reference protein, GAPDH (F), and their quantifications (E,G). The images were collected from different 
parts of the same gel with same loading amounts. The blot gels shown are representatives of five different 
experiments (n = 5) *indicates significant difference from control *p < 0.05, Scale bar = 20 μm.
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Iron induced ROS production in H9c2 cells. We next investigated the effect of iron on intracellular ROS 
production. This was first performed using the ROS indicator dye CellROX® red, and the representative 2- and 
3-dimensional fluorescent images in Fig. 4A and quantitation in B showed that appearance of ROS was increased 
upon iron treatment at 4 hr. A detailed quantitative and temporal study using live cell imaging is shown in Fig. 4D 
(also see Supplementary Video File) and this clearly indicated that ROS production reached a maximum after 3 hr 
and plateaued thereafter. The significant increase in intracellular ROS at 4 hr was further confirmed by detecting 
CellROX® red signal via flow cytometry (Fig. 4C). As expected, we found using fluorescent confocal imaging or flow 
cytometry that pretreatment of cardiomyocytes with MnTBAP, a superoxide dismutase (SOD) mimetic23, attenuated 
the overall increase in ROS after 4 hr iron exposure (Fig. 4E,F). To further investigate the source of ROS which was 
stimulated by iron, we pretreated in H9c2 cells with SkQ1, a specific inhibitor of mitochondrial ROS production24; 
Figure 3. Insulin signaling in cardiomyocyte indicated by increased phosphorylation of AKT T308 was all 
decreased by iron. Primary adult and neonatal cardiomyocytes with FeSO4 (100 μM) or without (con) were 
treated with insulin (100 nM) for 10 minutes before experimental endpoint. Representative confocal images 
of phosphorylation of AKT T308 in neonatal (A) and adult cardiomyocyte cells (F) and their quantifications 
(B,G). Western blots showing phosphorylation of AKT T308 and the reference protein, total AKT, in neonatal 
cardiomyocyte cells (C) its quantification (D). The images were collected from different parts of the same 
gel with same loading amounts. The blot gels shown are representatives of five different experiments (n = 5). 
Representative graph of the examined effect of FeSO4 (100 uM) for 1, 4, and 24hrs on glucose uptake (E). 
*Indicates significant difference from control without insulin; #Indicates significant difference from control 
respective to insulin 100 nM. *p < 0.05, Scale bar = 20 μm, (A,D n = 3, E n = 5, F,G n = 3).
5Scientific RepoRts | (2019) 9:4668 | https://doi.org/10.1038/s41598-019-41111-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
allopurinol, a specific xanthine oxidase inhibitor25,26 and apocynin, a specific NADPH oxidase inhibitor27. Both 
immunofluroscent images using CellROX® red and quantitative analysis of ROS production detected using DCFDA 
showed that iron induced ROS production was attenuated by SKQ1 and allopurinol but not apocynin (Fig. 4G,H).
Figure 4. Iron increased generation of reactive oxygen species (ROS) and enhanced by antioxidant (MnTBAP, 
100 μM). H9c2 cells with FeSO4 (100 μM) or without (con) were treated at 1 and 4hrs by CellROX Red assay and 
imaged by confocal microscope (A,E). Total red fluoresce of the confocal image was quantified and graphed (B) 
and shown in a time-lapse graph in live cells (D & Supplementary Video). The reactive oxygen species (ROS) 
production was examined by CellROX Red assay using flow cytometry (C,F) the high content system (G) and 
DCF-DA assay (H). *Indicates significant difference from control *p < 0.05, #Indicates significant difference 
from iron #p < 0.05, Scale bar = 20 μm, n = 4.
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Iron inhibited autophagy and reduced protein clearance in H9c2 cells. We next examined the 
potential mechanistic role of autophagy in regulating the effects of iron and first confirmed that at 4 hr of iron 
treatment, an increased amount of LC3-II and P62 was observed (Fig. 5A,B). When autophagic flux pathway 
is complete, autophagosomes will fuse with lysosome to get degraded. Interestingly, iron had no direct effect 
on expression of autophagy related proteins Atg7 and beclin-1 (Fig. 5C,D), or on phosphorylation of mTORC1 
S2448, ULK1 S757 and AMPK T172 (Fig. 5E,F). We next employed a non-radioactive, metabolic Click-iT 
HPG Alexa Fluor 488 labelling assay to quantify protein synthesis or degradation28 and examined effect of 4 hr 
iron in the presence or absence of chloroquine. Chloroquine-mediated blockade of the autophagy causes an 
Figure 5. Regulation of protein clearance by inhibition of autophagy and effect of iron. H9c2 cells were 
treated ± FeSO4 (100 μM) and ± chloroquine (60 nM) for 4 hrs. Representative western blotting for autophagy-
related genes (LC3II, P62, ATG7, Beclin-1, pmTORC1 S2448, pULK1 S757 and pAMPK T172) and the 
reference protein, GAPDH is shown (A,C,E). Corresponding quantifications of western blots are shown 
(B,D,F). Detection of protein synthesis/clearance was measured using Click-iT HPG Alexa Fluor 488 kit, and 
imaged by CX7 high content analysis microscopy from which representative images (G) and quantification are 
shown (H). Autophagosome detection using Cyto ID fluorescent probe and confocal microscopy is shown (I) 
and quantified (J). *Indicates significant difference from control *p < 0.05, #Indicates significant difference from 
iron #p < 0.05, Scale bar = 50 (G) and 20 (I) μm, n = 4.
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accumulation of protein which is also observed after 4 hr iron treatment, and their effects were not additive 
(Fig. 5G,H). To further determine the direct effect of iron on autophagy, we then used Cyto ID (green) to detect 
autophagosomes and found a significantly increased autophagosome accumulation at 4 hr iron treatment or, as 
expected, in the presence of chloroquine (Fig. 5I,J).
the mechanism via which iron reduced insulin signaling is via inhibition of autophagy. We 
examined the potential mechanistic role of autophagy in regulating effects of iron on insulin sensitivity. 
Autophagy flux was first analyzed via Western blotting for LC3 and p62 ± chloroquine and data indicated that 
iron inhibited autophagy flux (Fig. 6A–C). We also used AdiopoRON, an adiponectin receptor agonist, as a means 
to stimulate autophagy and indeed observed increased LC3-II levels without an increase in p62 (Fig. 6A–C). 
To further determine the effect of iron on autophagic flux, we then used Cyto ID (green) to detect autophago-
somes together with Magic Red (red) co-localization. Magic Red fluorescence indicates activity of the lysosomal 
cysteine protease cathepsin B29. Figure 6D,E shows that AdipoRon promoted co-localization of these signals 
which appear as yellow puncta, indicating increased autophagic flux, whereas distinct red and green signals were 
evident after iron treatment. Iron decreased Cyto ID with Magic Red co-localization yellow puncta in cardio-
myocytes. Addition of AdipoRon together with iron restored autophagic flux. Taken together, data indicate that 
iron inhibited overall autolysosomal activity and hindered autophagic flux. Figure 6F,G shows that, as expected, 
AdipoRon significantly increased the basal and insulin-stimulated phosphorylation of Akt and more interest-
ingly could significantly recover the inhibitory effect of iron on insulin signaling. These data suggest that insulin 
resistance caused by iron could be restored by rescuing the inhibition of autophagy. Based on these observations 
we generated a stable cell line with autophagy deficiency induced by overexpression of a dominant-negative Atg5 
mutant ATG5K130R30. With the use of autophagy deficient cells, there was an attenuation of dose dependent 
insulin-stimulated phosphorylation of Akt Thr308 compared to cells transfected with empty vector (Fig. 6H,I), 
indicating the requirement for adequate autophagic flux in maintaining insulin sensitivity. The ability of iron to 
induce insulin resistance was maintained in autophagy deficient cells, and a slightly enhanced effect was observed 
in response to 100 nM insulin (Fig. 6H,I).
Iron induced insulin resistance and reduction in autophagy flux occurred downstream of 
increased Ros production. We next evaluated whether iron-induced oxidative stress preceded reduced 
autophagy and Fig. 7A–C shows that iron-induced increases in the amount of p62 was significantly prevented by 
MnTBAP. Moreover, the ability of iron to induce insulin resistance was attenuated by using MnTBAP to reduce 
ROS production (Fig. 7D,E). Finally, we confirmed in primary adult rat cardiomyocytes that the amount of iron 
induced ROS production detected by CellROX® red was attenuated by MnTBAP (Fig. 7F,G). This correlated with 
the ability of MnTBAP to significantly reduce the ability of iron to induce insulin resistance in primary adult rat 
cardiomyocytes (Fig. 7H,I).
Discussion
Iron may play an underappreciated role in the development of insulin resistance and insulin resistance-induced 
heart failure. Insulin resistance and associated defective myocardial insulin signalling is an early and major factor 
in the development of heart failure31. Previous studies have suggested adverse cardiac remodeling in response to 
both iron or insulin overload and deficiency32. Numerous studies have demonstrated that increased serum ferritin 
is associated with insulin resistance and increased risk for diabetes33. We first investigated whether iron altered 
insulin sensitivity in IO and wt mice and we observed that the accumulation of serum and intracellular iron 
altered insulin resistance. To investigate mechanisms via which intercellular iron may induce insulin resistance in 
cardiomyocyte, we focused on oxidative stress. In the present study, we found that iron reduced insulin sensitivity 
via increased oxidative stress. Iron accumulation in H9c2 cells was done by treating them with iron. Using a col-
orimetric intracellular iron and PGSK assay, it was shown that there was significantly increased intracellular iron 
after treatment with iron for 1 4 and 24 hr. To assess the effect of iron overload on insulin resistance, pAKT T308 
was examined in H9c2 cells after treatment to induce iron overload conditions by Western blotting. We observed 
the same effect of iron in neonatal and adult cardiomyocyte cells and the data showed that reduced phosphoryla-
tion of AKT T308 at 1,4 and 24 hr by Western blotting and immunofluorescence.
Previous work has included evidence that iron-induced oxidative stress is a critical driver in the pathogen-
esis of myocardial tissue injury and progressive development of iron overload cardiomyopathy34. Excess iron 
promotes oxidative stress via the Fenton reaction, which plays a key pathogenic role in myocardial injury and 
heart failure35,36. Although many studies have described positive relationships between modulation of adipokines 
and insulin resistance, much importance has been placed on iron-mediated oxidant stress and the role it plays 
in the development of insulin resistance37. Our study suggested that using CellROX Deep Red assay we also 
observed that iron increased generation of ROS and that using anti-oxidant (MnTBAP) to attenuate ROS produc-
tion reduced the iron effect.
To investigate another novel mechanism via which iron may induce insulin resistance we focused on auto-
phagy. This important intracellular degradation machinery captures cytoplasmic components for lysosomal deg-
radation and recycling38 and previous evidence suggests that reduced autophagy occurs in the failing heart and is 
directly stimulated as a self-protective response in response to ischemia/reperfusion39,40. Autophagy is typically 
upregulated in times of stress, for example during ischemia/reperfusion, pressure overload and cardiac toxicity 
induced by chemicals such as the anthracycline doxorubicin41. Previous in vivo studies also have shown that the 
expression of multiple autophagy-related genes was altered in iron overload cardiomyopathy, possibly contrib-
uting to cardiac diastolic dysfunction42. Therefore, we used various assays designed to observe dynamic process 
of autophagic flux in order to carefully characterize the effect of iron. We observed that iron caused a significant 
upregulation of phosphorylation of ULK1 at Ser757 and LC3II. We also examined autophagic flux by testing 
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Figure 6. Regulation of insulin signaling by alterations in autophagy and effect of iron. H9c2 cells were treated 
with FeSO4 (100 μM) ± adipoRON (35 μM) and ± chloroquine (60 nM) for 4 hrs. Western blots showing 
protein expression of LC3II, P62 and the reference protein GAPDH, and their quantifications (B,C). Increase 
in autophagy by iron was validated by co localization of Cyto ID with Capthepsin D magic red assay (D) 
using confocal microscope and quantified (E). Insulin sensitivity was decreased in H9c2 cells as indicated by 
decreased phosphorylation of Akt T308. Western blots show phosphorylation of AKT T308 and the reference 
protein, total Akt (F), followed by their quantifications (G). Phosphorylation of AKT (T308) in autophagy-
impaired Atg5K cells is shown as representative western blot (H) and quantification (I). The images shown were 
collected from different regions of the same gel and are representatives of n = 5. *Indicates significant difference 
from control *p < 0.05, #Indicates significant difference from iron #p < 0.05, Scale bar = 20 μm, and in A–G 
n = 4.
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Figure 7. Iron induced insulin resistance via increased generation of reactive oxygen species (ROS), and 
enhanced by antioxidant (MnTBAP, 100 μM). H9c2 cells were treated at 4hrs with FeSO4 (100 μM) and 
antioxidant (MnTBAP, 100 μM). Western blots showing protein expression of LC3II, P62 and the reference 
protein GAPDH (A), followed by their quantifications (B,C). Insulin sensitivity was decreased in H9c2 cells 
as indicated by decreased phosphorylation of Akt T308; Western blots show phosphorylation of AKT T308 
and reference protein, total AKT (D), followed by its quantification (E). The images were collected from two 
gels with same loading amounts. The blot gels shown are representatives of four different experiments (n = 4). 
Representative confocal images of CellROX Red assay (F) and phosphorylation of AKT T308 (H) in adult 
cardiomyocyte cells and their quantifications (G,I). *Indicates significant difference from control *p < 0.05, 
#Indicates significant difference from iron #p < 0.05, Scale bar = 20 μm.
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p62 expression and found this was elevated by iron and chloroquine. LC3-II and p62 data collectively suggest 
iron attenuates flux. Cyto-ID is a fluorescent marker of autophagosomal puncta43 and both iron or chloroquine 
increased total amount of autophagosomes. We used the Click-iT® HPG Protein Synthesis Assay kit to gauge 
protein synthesis and it can also be used to monitor protein degradation28. Based on our data, we concluded 
that iron inhibited protein degradation, as did chloroquine, which is again in keeping with the phenomenon of 
reduced autophagy.
We have further examined the mechanistic role of autophagy in cardiac insulin sensitivity. To do so we used 
autophagy-deficient cell model by overexpressing a dominant-negative Atg5 mutant30. Our data suggested that 
iron overload and autophagy deficiency both induced insulin resistance and autophagy is a very important role of 
regulation insulin resistance in cardiomyocyte. Numerous studies suggested that dysregulation of autophagy leads 
to increases in oxidative stress44,45. For example, inhibition of autophagy by lysosome inhibitor chloroquine or the 
cathepsin D inhibitor pepstatin A increased ROS46,47. Additionally, the disorder of initiation of autophagy leads 
to accumulation of ubiquitinated proteins, induced ROS and elicited mitochondrial dysfunction48. Reduction 
of Atg5 and Atg10 expression exacerbated starvation-induced ROS44. Importantly, since our data indicated that 
inhibition of autophagic flux induced insulin resistance, we used AdipoRon, an adiponectin receptor agonist as an 
activator of autophagy49 and found that improved autophagy correlated with increased insulin signalling as well 
as attenuation of ROS production. The precise molecular mechanisms responsible for the connection between 
reduced autophagy and insulin resistance must be further explored and may include indirect effects via altering 
levels of oxidative or endoplasmic reticulum stress or a direct effect via autophagosomes playing a scaffolding 
role in formation of specific signaling complexes49. Overall, our study provides important new knowledge on a 
molecular mechanism contributing to insulin resistance. As a consequence, we propose that iron overload, as 
commonly found in type 2 diabetes, obesity and inflammatory conditions, leads to heart failure by attenuating 
levels of autophagy, inducing ROS and consequently insulin resistance.
Conclusions
In conclusion, our study indicated that iron induced insulin resistance in cardiomyocytes and this involved reg-
ulation of the crosstalk between autophagy and oxidative stress. Further studies will investigate mechanisms via 
which iron regulates cardiac remodeling and their physiological significance. We anticipate that our findings will 
provide new knowledge relevant to current diagnostics and therapeutics related to altered iron status in clinical 
settings.
Materials and Methods
Cell culture. The detailed method of growing H9c2 cells was based exactly as in a previous publication18. For 
assays specific to this project, cells were grown on cover slips where required and treated with or without FeSO4 
(100 μM) in DMEM with 0% FBS at approximately 60% confluency for 1, 4 and 24 hr. This dosage of iron is the 
range that is typically used by researchers in the field to modulate the activity of iron regulatory proteins (IRP1 
and IRP2) and trigger homeostatic responses to iron loading31.
Reagents. Apocynin (73536), FeSO4 (Ferrous Sulfate Heptahydrate, SIGMA-310077), MnTBAP (Mn 
(III) tetrakis (4-benzoic acid) porphyrin, 475870), Allopurinol (A8003) DCF-DA (D6883) were all from 
Sigma Aldrich. AdipoRON hydrochloride (5096) was from Tocris a biotechne brand and CellROX Deep Red 
Reagent (C10422) and Click-iT HPG Alexa Fluor 488 kit (C10428) were from Thermo Fisher Scientific. SkQ1 
[10-(6′-plastoquinonyl) decyltriphenylphosphonium] provided by Mitotech. Cyto-ID® autophagy detection kit 
(ENZ-51031) was from Enzo Life Sciences Inc and Magic Red Cathepsin-B Assay (938) from ImmunoChemistry 
Technologies LLC.
Isolation and culture of primary adult and neonatal rat cardiomyocytes. Adult Wistar male rats 
(age 6 to 10 wk) were used according to protocols approved by the Animal Care Committee at York University. 
Adult50 and neonatal51 primary cardiomyocytes were isolated and cultured exactly as previously described by us.
Generation of H9c2-ATG5K130R cells. To generate H9c2 cells stably over-expressing mutant ATG5 pro-
teins (ATG5K130R), H9c2 cells were transduced with retroviral vector carrying pmCherry-ATG5K130R as we 
previously described30.
Generation of a mouse model of acute iron overload. In house bred C57BL/6 (wild type, WT) mice 
(originally from Jackson Laboratory) were fed ad libitum on regular chow diet until 6–8 weeks of age and ran-
domly separated into treatment groups. Animals were injected with iron dextran (Sigma) at 15 mg per kg via tail 
vein, three times, with two hour intervals (ie. 0, 2 and 4 h). The amounts of iron we used here are close to pharma-
cological doses of intravenous iron used for the treatment of iron deficiency anemia52,53 and less than that used in 
models of pharmacological iron overload that have been used in the past and provided important pathophysio-
logical insights10,54. Tissues were harvested at 24 hour after initial injection. All animals were kept in temperature 
and humidity-control rooms (21 ± 2 °C, 35–40%) with a daily 12:12 h light-dark cycle in the animal care facility 
of York University in accordance to the guidelines of the Canadian Council on Animal Care. All study protocols 
were approved by the Animal Care Committee of York University.
serum iron measurement. Blood was collected via cardiac puncture. Serum was prepared by using micro 
Z-gel tubes with clotting activator (Sarstedt) and was snap-frozen at −80 °C. Serum iron was determined at 
the Biochemistry Department of the Jewish General Hospital (Montreal, Quebec) using a Roche Hitachi 917 
Chemistry Analyzer as previously described55.
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Histological analysis of myocardial iron deposition. Heart tissue samples were fixed in neutral- 
buffered 10% formalin for 18 h and subjected to routine histological processing. Tissue sections were then stained 
with Perl’s Prussian Blue and counterstained with hematoxylin. Iron detection using this approach was determined 
by light microscopy.
Analysis of iron content in heart homogenates and in H9c2 cells. Heart tissue homogenate sam-
ples were prepared as we described before30 H9C2 cells were lysed with 200ul of iron releasing agent (a freshly 
mixed solution of equal volumes of 1.4 M HCl and 4.5% (w/v) KMnO4 in H2O). The 24 well plates were sealed 
in aluminum foil and incubated at 60 °C for a duration of 2 hr. Afterward, 60ul of iron detecting reagent (2.5 M 
ammonium acetate +1 M ascorbic acid +6.5 mM ferrozine +6.5 mM Neocuproine: Sigma) was added to each 
well and left to incubate for 30 min at room temperature (RT). 280 ul of each reaction mixture was transferred to a 
96 well plate and the absorbance of each well was measured at a wavelength of 550 nm using a spectrophotometer. 
Data was normalized by the control treatment without iron.
Analysis of intracellular iron with the PG-SK fluorescent probe. H9C2 cells were treated with 
100 uM of FeSO4 for 1, 4 and 24 hour durations 30 minutes after loading with 3uM of PG-SK diacetate (Sigma). 
Coverslips were washed 4 times with 0.5 ml PBS++, fixed by covering coverslips with 10% formalin solution for 
30 min, washed again 3 times in PBS++, quenched by covering coverslips in 1% glycine solution for 15 minutes, 
washed once more 3 times in PBS++ and transferred onto slides using DAPI Mounting Media for fluorescence 
nuclear staining and ProLong antifade gold standard reagent (in a 1:2 ratio respectively). Prepared slides were 
viewed via laser scanning microscopy. PG-SK fluorescence was viewed using FITC and quantified by average 
fluorescent intensity per cell by dividing the total green fluorescence by cell number using ImageJ software.
Western blotting. Heart tissue was snap frozen and pulverized with mortar and pestle in liquid nitrogen. 
The powdered tissue was then suspended in lysis buffer exactly as we previously described56. H9c2 cells were 
grown to 90% confluency in 6 well plates. The detailed method was based on a previous publication18. The follow-
ing primary antibodies were used in this study: pAkt T308 (4026), Total Akt1 (9272), LC3B (2775), P62 (23214), 
Beclin-1 (3738), pmTORC1 S2448 (2971), pULK1 S757 (14202), pAMPK T172 (2535), p70S6K T389 (9234) and 
GAPDH (2118) were purchased from Cell Signalling Technology. pIR beta Y972 and pIRS-1 Y612 (44816) were 
purchased from Life Technology. Atg7 (376212) was purchased from Santa Cruz Biotechnology. The following 
secondary antibodies were used; anti-rabbit IgG HRP-linked antibody and anti-mouse IgG HRP-linked antibody 
from Cell Signalling Technology.
Analysis of glucose uptake. To determine glucose uptake, H9c2 cells were seeded in 24-well plates and 
treated with or without FeSO4 (100 μM) for periods of 1, 4 and 24 hr. Where indicated insulin was used at 100 nM 
for 10 min. Subsequently, glucose transport was assayed essentially as we previously described57 and results were 
calculated as pmol of glucose uptake per min per mg protein.
Detection of Ros using CellRoX® deep red or DCF-DA. CellROX® deep red oxidative stress rea-
gent (Life Technologies) which is non-fluorescent while in a reduced state and upon oxidation exhibits strong 
fluorogenic signal was used. H9c2 cells were seeded in 6-well plates, and treated 100 uM of FeSO4 for up to 4 hr. 
CellROX® deep Red was added in each well at 10ug/mL and incubated for 15 min. Cells were harvested and fixed 
with 4% PFA prior to analysis with confocal microscopy taken using 40 or 60X objective (LSM 700), or run in 
flow cytometer (Gallios ™, Beckman Coulter Inc.) to analyze red fluorescent signal intensity in each cell within 
a population of 100,000. Where indicated, H9C2 cells were treated 100 uM of FeSO4 and with various concentra-
tions of ROS inhibitors. Iron (Ferrous Sulfate Heptahydrate, FeSO4), MnTBAP (Mn (III) tetrakis (4-benzoic acid) 
porphyrin), Apocynin, and Allopurinol were all from Sigma Aldrich. SkQ1 [10-(6′-plastoquinonyl) decyltriphe-
nylphosphonium] provided by Mitotech. In using DCF-DA, cells were incubated for 4 hr with 20 μM DCF-DA 
(Sigma Aldrich) which is activated by ROS to generate a highly fluorescent 2′7′-dichlorofluorescein (DCF) mole-
cule. DCF fluorescence was measured at 490/530 nm using a Synergy H4 multimode plate reader (BioTek).
Cyto-ID® Green and Magic Red lysosomal cathepsin B activity for autophagy detection. The 
Cyto-ID® Green autophagy dye was prepared following the protocol from the manufacturer (Enzo Life Sciences 
Inc.). Magic Red assay was performed exactly as we have described before18. Confocal images were taken using 
40 or 60X objective (LSM 700).
Generation of 3D confocal images and time-lapse image acquisition. Images of the whole field 
were captured in 2D as well as in 3D (>100 z- stacks). These datasets were then loaded into IMARIS software 
(Bitplane Inc.) and 3D images generated. Video acquisitions were performed using a Nikon A1R confocal laser 
scanning microscope system (Nikon Corp., Tokyo, Japan). Video acquisition at a speed of 30 frames per sec-
ond was performed for the indicated times, followed by time-lapse imaging every 2 minute up to 4 hr after Iron 
treatment.
Metabolic Labeling of proteins synthesis assay. Click-iT® HPG Protein Synthesis Assay kit 
(Invitrogen) according to manufacturer’s instructions. Briefly, H9C2 cells were treated with 100 uM of FeSO4 
for 4 hr durations 30 minutes after loading with 50 μM Click-iT® HPG. Cell were washed 1 time then proceed to 
15 min fixation with 10% formalin solution and 20 min permeabilization with 0.5% Triton X. Remove the perme-
abilization buffer and wash cells twice 3% BSA in PBS. Remove the wash solution and add cocktail to each well 
and mix well and incubate for 30 min at room temperature, protected from light. Remove the reaction cocktail 
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and wash once with Click-iT® reaction rinse buffer. Remove the Click-iT® reaction rinse buffer and staining with 
DNA Staining. Scan plate using automated imaging platform with filters appropriate for DAPI/ Hoechst and FITC 
for Alexa Fluor® 488.
statistical analyses. Data was presented as mean ± SEM. Statistical significance between treatment groups 
were calculated using the unpaired Student t test when comparing 2 groups. For comparisons of more than 2 
groups, One Way ANOVA followed by Dunnett’s post-test and Two Way ANOVA with Bonferroni post-test were 
performed to adjust multiple comparisons. P value < 0.05 was considered statistically significant.
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